Neuronetics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Neuronetics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $4.00K.
- Neuronetics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $1.00K.
- Neuronetics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $8.00K.
- Neuronetics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $43.00K, a 93.95% decline year-over-year.
- Neuronetics, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $12.00K.
- Neuronetics, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $298.00K, a 87.76% decline from fiscal 2021.
- Neuronetics, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $2.44M, a 252.90% increase from fiscal 2020.
- Neuronetics, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $690.00K, a 71.49% decline from fiscal 2019.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $12.00K 10-K · filed 2026-03-17 | |
| 2025-09-30 | $4.00K 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $1.00K 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $8.00K 10-Q · filed 2026-08-11 | |
| 2022-12-31 | $298.00K 10-K · filed 2025-03-27 | |
| 2022-06-30 | $43.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $9.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $2.44M 10-K · filed 2024-03-08 | |
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $711.00K 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $1.59M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $690.00K 10-K · filed 2023-03-07 | |
| 2020-09-30 | $410.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $48.00K 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $76.00K 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $2.42M 10-K · filed 2022-03-08 | |
| 2019-09-30 | $443.00K 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $470.00K 10-Q · filed 2020-11-02 | |
| 2019-03-31 | $1.41M 10-Q · filed 2020-11-02 | |
| 2018-12-31 | $503.00K 10-K · filed 2021-03-02 | |
| 2018-09-30 | $7.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $7.00K 10-Q · filed 2019-11-05 | |
| 2018-03-31 | $31.00K 10-Q · filed 2019-11-05 | |
| 2017-12-31 | $35.00K 10-K · filed 2020-03-03 | |
| 2016-12-31 | $67.00K 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |